Flumazenil Injection, Solution
Product Images NDC 51662-1579

10 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 51662-1579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Description (Description)
Chemical structure of flumazenil, showing its molecular formula C15H14FN3O3 and molecular weight 303.3. The diagram depicts the arrangement of rings and functional groups typical for this active ingredient.*
FDA Label Image

Cp1 (Cp 1)

Cp1 (Cp 1)
A line graph depicting the magnitude and duration of reversal of sedation as a function of Flumazenil dose (0.2, 0.6, and 1 mg) by blood level in ng/mL. The y-axis represents alertness levels (sedated to completely alert), and the x-axis shows minutes after Flumazenil injection. The graph illustrates varying alertness trajectories over time for each dose in healthy volunteers.*
FDA Label Image

Cp2 (Cp 2)

Cp2 (Cp 2)
A data table presenting pharmacokinetic parameters including Cmax, AUC, Vss, Cl, and half-life with values, variability percentages, and ranges for the drug Flumazenil Injection, 0.1 mg/mL.*
FDA Label Image

Warnings (Warnings)

Warnings (Warnings)
A warning text panel for Flumazenil injection, solution, 0.1 mg/mL. It states that Flumazenil use has been associated with seizures, especially in patients on long-term benzodiazepines or with signs of serious cyclic antidepressant overdose. It advises practitioners to individualize dosage and be prepared to manage seizures.*
FDA Label Image

Hs (Hs)

Hs (Hs)
A data table listing Flumazenil Injection USP products with NDC codes, strengths, vial sizes, and packaging details. It includes 0.5 mg per 5 mL (0.1 mg/mL) in 5 mL multiple dose vials packaged in trays of 10, and 1 mg per 10 mL (0.1 mg/mL) in 10 mL multiple dose vials packaged individually.*
FDA Label Image
FDA Label Image

Label (51662 1579 1 Rfid Label)

Label (51662 1579 1 Rfid Label)
A white rectangular label on a product box for FLUMAZENIL injection solution distributed by HF Acquisition Co., LLC. The label includes multiple identification codes, a QR-like matrix barcode, the instruction to see the manufacturer's insert, and states RX ONLY with the distributor's address in Mukilteo, WA 98275.*
FDA Label Image

Vial Labeling (51662 1579 1 Vial Labeling)

Vial Labeling (51662 1579 1 Vial Labeling)
Label for Flumazenil Injection, USP 0.5 mg per 5 mL (.1 mg per mL) sterile solution for intravenous use only. The label indicates a 5 mL multiple dose vial, produced by Fresenius Kabi, Lake Zurich, IL. Storage instructions are to keep between 20° to 25°C (68° to 77°F). Additional formulation and packaging details are included.*
FDA Label Image

Label (51662 1579 2 Pouch)

Label (51662 1579 2 Pouch)
FLUMAZENIL injection label showing a concentration of 0.1 mg/mL with a 5 mL vial size. The label includes NDC 51662-1579-2, lot number 789210, and an expiration date of 2030-09-19. It is distributed by HF Acquisition Co., LLC, DBA HealthFirst, Mukilteo, WA, and intended for intravenous use only.*
FDA Label Image

Label (51662 1579 3 Case Label)

Label (51662 1579 3 Case Label)
Label for Flumazenil Injection USP 0.1 mg/mL in a 5 mL vial, packaged as a case of 10 vials. The label includes product NDC 51662-1579-3, lot number 789210, and expiration date September 19, 2030. Distributed by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.